MetLife Investment Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $936K | Buy |
23,095
+790
| +4% | +$32K | 0.01% | 1349 |
|
|
2025
Q1 | $1.15M | Sell |
22,305
-373
| -2% | -$19.2K | 0.01% | 1291 |
|
|
2024
Q4 | $1.26M | Buy |
22,678
+1,174
| +5% | +$65K | 0.01% | 1299 |
|
|
2024
Q3 | $707K | Hold |
21,504
| – | – | ﹤0.01% | 1591 |
|
|
2024
Q2 | $584K | Buy |
21,504
+5,964
| +38% | +$162K | ﹤0.01% | 1637 |
|
|
2024
Q1 | $565K | Hold |
15,540
| – | – | ﹤0.01% | 1607 |
|
|
2023
Q4 | $315K | Buy |
15,540
+2,772
| +22% | +$56.1K | ﹤0.01% | 1963 |
|
|
2023
Q3 | $227K | Hold |
12,768
| – | – | ﹤0.01% | 2133 |
|
|
2023
Q2 | $231K | Buy |
12,768
+2,094
| +20% | +$37.8K | ﹤0.01% | 2186 |
|
|
2023
Q1 | $134K | Hold |
10,674
| – | – | ﹤0.01% | 2432 |
|
|
2022
Q4 | $156K | Hold |
10,674
| – | – | ﹤0.01% | 2398 |
|
|
2022
Q3 | $183K | Hold |
10,674
| – | – | ﹤0.01% | 2354 |
|
|
2022
Q2 | $156K | Buy |
+10,674
| New | +$156K | ﹤0.01% | 2473 |
|
|
2021
Q1 | – | Sell |
-3,250
| Closed | -$134K | – | 2333 |
|
|
2020
Q4 | $134K | Buy |
+3,250
| New | +$134K | ﹤0.01% | 2169 |
|